23.1 C
Abuja

NAFDAC to continue with clinical trials on chloroquine despite WHO’s reservations

Advertisement

Related

Advertisement
Advertisement

ON Tuesday, the National Agency for Food and Drug Administration and Control, NAFDAC, announced it would proceed with hydroxychloroquine clinical trials for the treatment of COVID-19 in Nigeria after the World Health Organisation, WHO, suspended testing following a study on its effects on COVID-19 patients.

In a report, the NAFDAC Director-General, Mojisola Adeyeye, said there are proven records that hydroxychloroquine had been effective in the treatment of COVID-19 patients, especially those at the “mild stage” of the virus.

“There is data to prove that hydroxychloroquine worked for many COVID-19 patients. Therefore, we would continue our own clinical trials in Nigeria. Hydroxychloroquine has been proved to work at a mild stage. So the potency depends on the severity of the disease in the patient’s body,” she said.

Mojisola stated the hydroxychloroquine clinical trials had begun in earnest, but its conclusion depends on the speed of work which could be in three to four months.

“If medical doctors, research scientists, pharmacists, herbal experts work together, we should conclude the clinical trial in three to four months. The narrative might change afterward but for now, we believe in hydroxychloroquine,” she said.

In a study published in the Lancet, peer-reviewed journal over 96,000 virus patients were examined and most of them had a higher risk of abnormal heartbeats, or arrhythmias, that could cause a heart attack in those treated with hydroxychloroquine or chloroquine.

WHO announced that it was “temporarily” suspending the clinical trials of chloroquine as a potential treatment for COVID-19 saying the decision was a temporary measure.

- Advertisement -

The global health body said other arms of the so-called ‘Solidarity trial’ – a major international initiative to hold clinical tests of potential treatments for the virus – were continuing.

Director-General of the WHO, Tedros Adhanom Ghebreysus hinted its safety board was still reviewing the drug until a final position is taken.

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial, while the safety data is reviewed by the data safety monitoring board. The other arms of the trial are continuing,” he said.

He emphasised that hydroxychloroquine and chloroquine “are accepted as generally safe for use in patients with autoimmune diseases or malaria,” noting that the suspension was a temporary measure.

The Lancet study looked at patient medical records in 671 hospitals across six continents, making it the most extensively published evaluation of the drug’s impacts on coronavirus patients.

Author profile

Amos Abba is a journalist with the International Center for Investigative Reporting, ICIR, who believes that courageous investigative reporting is the key to social justice and accountability in the society.

Support the ICIR

We invite you to support us to continue the work we do.

Your support will strengthen journalism in Nigeria and help sustain our democracy.

[molongui_author_box]

If you or someone you know has a lead, tip or personal experience about this report, our WhatsApp line is open and confidential for a conversation

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Support the ICIR

We need your support to produce excellent journalism at all times.

Advertisement

Recent

Train attack: How FG met terrorists’ demands for release of abducted passengers

SENIOR Special Assistant to the President on Media and Publicity Garba Shehu has said...

NNPCLtd. signs contract extension with oil majors, targets $500bn investments

THE Nigerian National Petroleum Company Limited (NNPCLtd) has signed a contract extension with five...

Bandits kill two vigilantes in Abuja

TWO vigilante members have been reported dead following an encounter with bandits at Gasakpa...

Wike to Atiku: People around you may cost you 2023 presidential election

RIVERS State governor Nyesom Wike has advised candidate of the Peoples Democratic Party (PDP)...

Aero Contractors eyes return to commercial operations

Aero Contractors is eyeing a return to commercial operations after the temporary suspension of...
Advertisement

Most Read

Advertisement

Subscribe to our newsletter

Advertisement